Delivery Order SPE2DB20D2014-SPE2DB26FA18K
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,275.84 to AmerisourceBergen Drug Corp for Risperidone 3 mg tablets (60-count units) on September 4, 2025, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and represents a routine pharmaceutical supply transaction for federal medical operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,054.47 to AmerisourceBergen Drug Corp for the supply of Risperidone 2 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on April 24, 2025, with an ultimate completion date of April 25, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperidone 3 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of approximately $2.1K. The award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive delivery order executed through AmerisourceBergen's existing indefinite delivery contract vehicle with DLA. Performance will occur at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Risperidone 3 mg tablets in a quantity of 60 units, with a ceiling value of $1,816.53 and a firm fixed-price contract type. The order is not set-aside and represents a competitive award to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperidone 0.5 mg tablets in a 60-count quantity, with a ceiling value of $1,310.34. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order valued at $19,860.64 to AmerisourceBergen Drug Corp for the supply of Risperidone 3 mg tablets in quantities of 500 units. This is a firm fixed-price delivery order with an ultimate completion date of April 24, 2025, and no set-aside designation was used in the award. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units at a firm fixed price of $2,213.75. The contract carries an ultimate completion date of July 17, 2025, and represents a non-set-aside, competitively awarded procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $1,965.54 and an ultimate completion date of October 20, 2025. The contract was awarded without set-aside provisions through competitive procurement, and the place of performance is located in Conshohocken, Pennsylvania, which is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units. This firm fixed-price delivery order carries a ceiling value of $2,620.44 and is scheduled for completion by October 21, 2025. The contract represents a non-competitive award under an existing indefinite delivery contract vehicle, with performance occurring at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperidone 0.5 mg tablets (60-count) with a firm fixed price ceiling value of $6,580.29. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 4, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999 and...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA18KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,115.09 to AmerisourceBergen Drug Corp for the supply of Risperidone 3 mg tablets in quantities of 60 units. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with an ultimate completion date of October 27, 2025. The award was made on October 24, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other federal agencies. The IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill federal medical supply requirements across multiple therapeutic domains, including neurological, pain management, and other specialty medications for military health programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 10/24/25 |